Inefficient export of viral late mRNA contributes to fastidiousness of human adenovirus type 41 (HAdV-41) in 293 cells

Virology

Volumn 468, Issue , 2014, Pages 388-396

  Zou, Xiao Hui ^a   Li, Wen Jia ^b   Guo, Xiao Juan ^a   Qu, Jian Guo ^a   Wang, Min ^a   Si, Hong Li ^b   Lu, Zhuo Zhuang ^a   Hung, Tao ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Adenovirus type 41; E1B55K; E4orf6; Fastidiousness; MRNA export

Indexed keywords

MESSENGER RNA; PROTEIN E1B55K; PROTEIN E4ORF6; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ARTICLE; CODON; CONTROLLED STUDY; HEK293 CELL LINE; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 41; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; NONHUMAN; OPEN READING FRAME; PLASMID; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY;

HUMAN ADENOVIRUS TYPE 41;

ADENOVIRUSES, HUMAN; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; MUTATION; PLASMIDS; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

EID: 84907463124     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.08.027     Document Type: Article

References (50)

1. Albinsson B., Kidd A.H. Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells. Virus Res. 1999, 64:125-136.
2. Allard A., Wadell G. The E1B transcription map of the enteric adenovirus type 41. Virology 1992, 188:319-330.
3. Babiss L.E., Ginsberg H.S., Darnell J.E. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol.ogy 1985, 5:2552-2558.
4. Baker A., Rohleder K.J., Hanakahi L.A., Ketner G. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 2007, 81:7034-7040.
5. Blackford A.N., Grand R.J. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J. Virol. 2009, 83:4000-4012.
6. Blackford A.N., Patel R.N., Forrester N.A., Theil K., Groitl P., Stewart G.S., Taylor A.M., Morgan I.M., Dobner T., Grand R.J., Turnell A.S. Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:12251-12256.
7. Cheng C.Y., Gilson T., Dallaire F., Ketner G., Branton P.E., Blanchette P. The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity. J. Virol. 2011, 85:765-775.
8. Cheng C.Y., Gilson T., Wimmer P., Schreiner S., Ketner G., Dobner T., Branton P.E., Blanchette P. Role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes. J. Virol. 2013, 87:6232-6245.
9. Croyle M.A., Stone M., Amidon G.L., Roessler B.J. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene. Ther. 1998, 5:645-654.
10. Dallaire F., Blanchette P., Groitl P., Dobner T., Branton P.E. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 2009, 83:5329-5338.
11. Di Paolo N.C., Miao E.A., Iwakura Y., Murali-Krishna K., Aderem A., Flavell R.A., Papayannopoulou T., Shayakhmetov D.M. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 2009, 31:110-121.
12. Favier A.L., Schoehn G., Jaquinod M., Harsi C., Chroboczek J. Structural studies of human enteric adenovirus type 41. Virology 2002, 293:75-85.
13. Forrester N.A., Sedgwick G.G., Thomas A., Blackford A.N., Speiseder T., Dobner T., Byrd P.J., Stewart G.S., Turnell A.S., Grand R.J. Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection. J. Virol. 2011, 85:2201-2211.
14. Gao W., Robbins P.D., Gambotto A. Human adenovirus type 35: nucleotide sequence and vector development. Gene. Ther. 2003, 10:1941-1949.
15. Gupta A., Jha S., Engel D.A., Ornelles D.A., Dutta A. Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene 2013, 32:5017-5025.
16. Halbert D.N., Cutt J.R., Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 1985, 56:250-257.
17. Harada J.N., Shevchenko A., Shevchenko A., Pallas D.C., Berk A.J. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 2002, 76:9194-9206.
18. Holterman L., Vogels R., van der Vlugt R., Sieuwerts M., Grimbergen J., Kaspers J., Geelen E., van der Helm E., Lemckert A., Gillissen G., Verhaagh S., Custers J., Zuijdgeest D., Berkhout B., Bakker M., Quax P., Goudsmit J., Havenga M. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J. Virol. 2004, 78:13207-13215.
19. Howell G.M., Gustafsson J.A., Lefebvre Y.A. Glucocorticoid receptor identified on nuclear envelopes of male rat livers by affinity labeling and immunochemistry. Endocrinology 1990, 127:1087-1096.
20. Kidd A.H., Chroboczek J., Cusack S., Ruigrok R.W. Adenovirus type 40 virions contain two distinct fibers. Virology 1993, 192:73-84.
21. Kidd A.H., Cosgrove B.P., Brown R.A., Madeley C.R. Faecal adenoviruses from Glasgow babies. Studies on culture and identity. J. Hyg. (Lond.) 1982, 88:463-474.
22. Kim M., Lim M.Y., Ko G. Enhancement of enteric adenovirus cultivation by viral transactivator proteins. Appl. Environ. Microbiol. 2010, 76:2509-2516.
23. Lemiale F., Haddada H., Nabel G.J., Brough D.E., King C.R., Gall J.G. Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41. Vaccine 2007, 25:2074-2084.
24. Liu H.Y., Han B.J., Zhong Y.X., Lu Z.Z. A three-plasmid system for construction of armed oncolytic adenovirus. J. Virol. Methods 2009, 162:8-13.
25. Louis N., Evelegh C., Graham F.L. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 1997, 233:423-429.
26. Lu Z.Z., Zou X.H., Dong L.X., Qu J.G., Song J.D., Wang M., Guo L., Hung T. Novel recombinant adenovirus type 41 vector and its biological properties. J. Gene. Med. 2009, 11:128-138.
27. Lu Z.Z., Zou X.H., Lastinger K., Williams A., Qu J.G., Estes D.M. Enhanced growth of recombinant human adenovirus type 41 (HAdV-41) carrying ADP gene. Virus Res. 2013, 176:61-68.
28. Mautner V. Growth and purification of enteric adenovirus type 40. Methods Mol. Med. 2007, 130:145-156.
29. Mautner V., Bailey A., Steinthorsdottir V., Ullah R., Rinaldi A. Properties of the adenovirus type 40 E1B promoter that contribute to its low transcriptional activity. Virology 1999, 265:10-19.
30. Natalizio B.J., Wente S.R. Postage for the messenger: designating routes for nuclear mRNA export. Trends Cell Biol. 2013, 23:365-373.
31. Orazio N.I., Naeger C.M., Karlseder J., Weitzman M.D. The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J. Virol. 2011, 85:1887-1892.
32. Pieniazek D., Pieniazek N.J., Macejak D., Coward J., Rayfield M., Luftig R.B. Differential growth of human enteric adenovirus 41 (TAK) in continuous cell lines. Virology 1990, 174:239-249.
33. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 2001, 15:3104-3117.
34. Querido E., Chu-Pham-Dang H., Branton P.E. Identification and elimination of an aberrant splice product from cDNAs encoding the human adenovirus type 5 E4orf6 protein. Virology 2000, 275:263-266.
35. Schmid M., Kindsmuller K., Wimmer P., Groitl P., Gonzalez R.A., Dobner T. The E3 ubiquitin ligase activity associated with the adenoviral E1B-55K-E4orf6 complex does not require CRM1-dependent export. J. Virol. 2011, 85:7081-7094.
36. Schreiner S., Wimmer P., Dobner T. Adenovirus degradation of cellular proteins. Future Microbiol. 2012, 7:211-225.
37. Schreiner S., Wimmer P., Sirma H., Everett R.D., Blanchette P., Groitl P., Dobner T. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J. Virol. 2010, 84:7029-7038.
38. Sheinberger J., Shav-Tal Y. The dynamic pathway of nuclear RNA in eukaryotes. Nucleus 2013, 4:195-205.
39. Sherwood V., Burgert H.G., Chen Y.H., Sanghera S., Katafigiotis S., Randall R.E., Connerton I., Mellits K.H. Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation. J. Gen. Virol. 2007, 88:71-76.
40. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol. 1998, 18:3112-3119.
41. Stracker T.H., Carson C.T., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418:348-352.
42. Tiemessen C.T., Kidd A.H. The subgroup F adenoviruses. J. Gen. Virol. 1995, 76(Pt 3):481-497.
43. van Loon A.E., Ligtenberg M., Reemst A.M., Sussenbach J.S., Rozijn T.H. Structure and organization of the left-terminal DNA regions of fastidious adenovirus types 40 and 41. Gene 1987, 58:109-126.
44. Vogels R., Zuijdgeest D., van Rijnsoever R., Hartkoorn E., Damen I., de Bethune M.P., Kostense S., Penders G., Helmus N., Koudstaal W., Cecchini M., Wetterwald A., Sprangers M., Lemckert A., Ophorst O., Koel B., van Meerendonk M., Quax P., Panitti L., Grimbergen J., Bout A., Goudsmit J., Havenga M. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 2003, 77:8263-8271.
45. Weinberg D.H., Ketner G. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J. Virol. 1986, 57:833-838.
46. Woo J.L., Berk A.J. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 2007, 81:575-587.
47. Yamasaki S., Miura Y., Brown E., Davydova J., Yamamoto M. Development of a method for effective amplification of human adenovirus 40. Arch. Virol. 2010, 155:1059-1068.
48. Yatherajam G., Huang W., Flint S.J. Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor. J. Virol. 2011, 85:1429-1438.
49. Yeh H.Y., Pieniazek N., Pieniazek D., Gelderblom H., Luftig R.B. Human adenovirus type 41 contains two fibers. Virus. Res. 1994, 33:179-198.
50. Zou X.H., Xiao X., Chen D.L., Li Z.L., Song J.D., Wang M., Qu J.G., Lu Z.Z., Hung T. An improved HAdV-41 E1B55K-expressing 293 cell line for packaging fastidious adenovirus. J. Virol. Methods 2011, 175:188-196.